DK523277A - Fremgangsmaade til fremstilling af et farmaceutisk praeparat med protraheret virkning - Google Patents

Fremgangsmaade til fremstilling af et farmaceutisk praeparat med protraheret virkning

Info

Publication number
DK523277A
DK523277A DK523277A DK523277A DK523277A DK 523277 A DK523277 A DK 523277A DK 523277 A DK523277 A DK 523277A DK 523277 A DK523277 A DK 523277A DK 523277 A DK523277 A DK 523277A
Authority
DK
Denmark
Prior art keywords
preparation
protrade
procedure
effect
pharmaceutical
Prior art date
Application number
DK523277A
Other languages
English (en)
Other versions
DK150534C (da
DK150534B (da
Inventor
Y Raghunathan
Original Assignee
Pennwalt Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pennwalt Corp filed Critical Pennwalt Corp
Publication of DK523277A publication Critical patent/DK523277A/da
Publication of DK150534B publication Critical patent/DK150534B/da
Application granted granted Critical
Publication of DK150534C publication Critical patent/DK150534C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
DK523277A 1976-11-26 1977-11-25 Fremgangsmaade til fremstilling af et farmaceutisk praeparat med forsinket afgivelse af en aktiv bestanddel DK150534C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US74532576A 1976-11-26 1976-11-26
US74532576 1976-11-26
US80010577A 1977-05-24 1977-05-24
US80010577 1977-05-24

Publications (3)

Publication Number Publication Date
DK523277A true DK523277A (da) 1978-05-27
DK150534B DK150534B (da) 1987-03-23
DK150534C DK150534C (da) 1987-10-12

Family

ID=27114439

Family Applications (1)

Application Number Title Priority Date Filing Date
DK523277A DK150534C (da) 1976-11-26 1977-11-25 Fremgangsmaade til fremstilling af et farmaceutisk praeparat med forsinket afgivelse af en aktiv bestanddel

Country Status (21)

Country Link
JP (1) JPS609697B2 (da)
AR (1) AR218047A1 (da)
AT (1) AT359197B (da)
AU (1) AU511080B2 (da)
BE (1) BE861141A (da)
CA (1) CA1086226A (da)
CH (1) CH639560A5 (da)
DE (1) DE2752728C2 (da)
DK (1) DK150534C (da)
FI (1) FI65910C (da)
FR (1) FR2373288A1 (da)
GB (1) GB1544761A (da)
GR (1) GR61724B (da)
IE (1) IE45998B1 (da)
IL (1) IL53462A (da)
LU (1) LU78584A1 (da)
NL (1) NL182283C (da)
NO (1) NO147626C (da)
NZ (1) NZ185772A (da)
PT (1) PT67323B (da)
SE (1) SE426781B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2929456A1 (de) 1979-07-20 1981-02-05 Lentia Gmbh Zusammensetzung mit verlaengerter broncholytischer und tokolytischer wirksamkeit, ein verfahren zu deren herstellung und broncholytisch und tokolytisch wirkendes mittel
CA1236023A (en) * 1984-07-18 1988-05-03 Yegnaswami Raghunathan Controlled release pharmaceutical preparations
US4692462A (en) * 1985-03-18 1987-09-08 Menley & James Laboratories, Ltd. Compositions and method of controlling transdermal penetration of topical and systemic agents
US5612059A (en) * 1988-08-30 1997-03-18 Pfizer Inc. Use of asymmetric membranes in delivery devices
US5188825A (en) * 1989-12-28 1993-02-23 Iles Martin C Freeze-dried dosage forms and methods for preparing the same
EP0542926B1 (en) * 1990-08-07 1995-02-15 Pfizer Inc. Use of interfacially-polymerized membranes in delivery devices
US5436011A (en) * 1993-04-16 1995-07-25 Bristol-Myers Squibb Company Solid pharmaceutical dosage form and a method for reducing abrasion
US20130230587A1 (en) * 2010-11-10 2013-09-05 Rubicon Research Private Limited Sustained release compositions
FR3059903B1 (fr) * 2016-12-08 2019-03-22 Salsarulo Pharma Medicament oral comprenant un laxatif osmotique incorpore dans une matrice a base de matieres grasses vegetales
WO2019074829A1 (en) 2017-10-09 2019-04-18 Rhodes Pharmaceuticals L.P. RESINATE-BASED PHARMACEUTICAL COMPOSITIONS, AND METHODS OF MAKING AND USING THEM

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE550150A (da) * 1955-08-08
GB843118A (en) * 1957-02-13 1960-08-04 Ici Ltd Pharmaceutical compositions containing piperidine derivatives
US3158538A (en) * 1961-02-23 1964-11-24 White Lab Inc Antidiarrheal compositions and method of using
GB982150A (en) * 1961-09-29 1965-02-03 Glaxo Group Ltd Therapeutic resin complexes
US3594470A (en) * 1968-02-19 1971-07-20 Abbott Lab Chewable tablets including coated particles of pseudoephedrine-weak cation exchange resin
GB1218102A (en) * 1968-03-15 1971-01-06 Philips Nv Improvements in medicaments comprising drug/ion-exchange resin compounds
CA927282A (en) * 1968-09-03 1973-05-29 S. Banker Gilbert Entrapment compositions and processes
CA935092A (en) * 1968-09-03 1973-10-09 S. Banker Gilbert Molecular drug entrapment process and compositions
DE2343218C2 (de) * 1973-08-28 1986-08-07 Hoechst Ag, 6230 Frankfurt Furosemid enthaltende Pellets

Also Published As

Publication number Publication date
FR2373288B1 (da) 1980-06-13
JPS609697B2 (ja) 1985-03-12
NO147626C (no) 1983-05-25
ATA848077A (de) 1980-03-15
GR61724B (en) 1978-12-29
NL182283C (nl) 1988-02-16
IL53462A0 (en) 1978-01-31
CA1086226A (en) 1980-09-23
DE2752728A1 (de) 1978-06-01
NZ185772A (en) 1978-12-18
AR218047A1 (es) 1980-05-15
DK150534C (da) 1987-10-12
IE45998L (en) 1978-05-26
JPS5369822A (en) 1978-06-21
SE426781B (sv) 1983-02-14
FI773568A (fi) 1978-05-27
SE7713370L (sv) 1978-05-27
DE2752728C2 (de) 1985-08-01
PT67323B (en) 1979-04-24
AU3098677A (en) 1979-05-31
IL53462A (en) 1980-12-31
AT359197B (de) 1980-10-27
BE861141A (fr) 1978-03-16
GB1544761A (en) 1979-04-25
FI65910C (fi) 1984-08-10
FI65910B (fi) 1984-04-30
NO147626B (no) 1983-02-07
PT67323A (en) 1977-12-01
CH639560A5 (en) 1983-11-30
NL182283B (nl) 1987-09-16
LU78584A1 (da) 1978-04-20
IE45998B1 (en) 1983-01-26
NL7712996A (nl) 1978-05-30
NO774051L (no) 1978-05-29
AU511080B2 (en) 1980-07-24
FR2373288A1 (fr) 1978-07-07
DK150534B (da) 1987-03-23

Similar Documents

Publication Publication Date Title
DK371277A (da) Fremgangsmaade til fremstilling af farmaceutiske doseringsformer med vedvarende virkning
DK113676A (da) Fremgangsmade til fremstilling af et retardpreparat
DK142372C (da) Fremgangsmaade til fremstilling af androstan-17-on-derivater
DK377A (da) Fremgangsmade til fremstilling af n-phosphonomethyl-glycin
DK244577A (da) Fremgangsmade til fremstilling af hydantoinderivater
DK334077A (da) Fremgangsmade til fremstilling af et polysaccharid
DK523277A (da) Fremgangsmaade til fremstilling af et farmaceutisk praeparat med protraheret virkning
DK339677A (da) Fremgangsmade til fremstilling af 2-benzylpyrrolidiner
DK271977A (da) Fremgangsmade til fremstilling af dispeptidderivater
DK352578A (da) Fremgangsmaade til fremstilling af et farmaceutisk praeparat
DK46577A (da) Fremgangsmade til fremstilling af tetrahydroechinocandinderivater
DK118177A (da) Fremgangsmade til fremstilling af isobutyramidderivater
DK144377A (da) Fremgangsmade til fremstilling af acylcyanider
DK151878C (da) Fremgangsmaade til fremstilling af et 2-substitueret benzanilid
DK143173C (da) Fremgangsmaade til fremstilling af et urinstof-urinstofphosphatholdigt droevtyggerfoder
DK216977A (da) Fremgangsmade til fremstilling af imidazobenzoxaziner
DK144277A (da) Fremgangsmade til fremstilling af acylcyanider
DK264377A (da) Fremgangsmade til fremstilling af 1alfa-hydroxycholesterol-derivater
DK345277A (da) Fremgangsmaade til fremstilling af tetrahydropyridinderivater
DK235277A (da) Fremgangsmade til fremstilling af et polysaccharid
DK196577A (da) Fremgangsmade til fremstilling af kolecystokinin-pankreozymin-oktapeptidamidsulfatester
DK538977A (da) Fremgangsmaade til fremstilling af 17alfa-hydroxy-21-acetoxy-progesteron
DK568278A (da) Fremgangsmaade til fremstilling af et pharmaceutisk praeparat
DK106677A (da) Fremgangsmade til fremstilling af 3-nethylencephalosporiner
DK338677A (da) Frefmgangsmade til fremstilling af 3-alkoxycyproheptadiner

Legal Events

Date Code Title Description
PUP Patent expired